Office evaluation of the obese patient

Clinics in Family Practice

Volumn 4, Issue 2, 2002, Pages 351-367

  Wyatt, Holly R ^a,b,c   Hill, James O ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CLONIDINE; CYPROHEPTADINE; DIPHENHYDRAMINE; GLUCOCORTICOID; INSULIN; LITHIUM; METFORMIN; PHENOTHIAZINE; PROPANOL; SULFONYLUREA; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANAMNESIS; ANTHROPOMETRY; ARTICLE; BODY MASS; CANCER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; EVALUATION; FEMALE; GASTROINTESTINAL DISEASE; GENITAL SYSTEM DISEASE; HUMAN; LABORATORY TEST; LONG TERM CARE; LUNG DISEASE; MALE; MENTAL DISEASE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; OBESITY; PATIENT SELECTION; RISK ASSESSMENT; SIDE EFFECT; SKIN DISEASE; TREATMENT PLANNING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0036623679     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(02)00013-2     Document Type: Review

References (35)

1. Kuczmarski RJ, Carrol MD, Flegal KM, et al. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988-1994). Obes Res 1997;5:542-8.
2. Dyer AR, Elliott P. The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens 1989;3: 299-308.
3. Larsson B, Bjorntorp P, Tibblin G. The health consequences of moderate obesity. Int J Obes 1981;5:97-116.
4. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32:563-76.
5. Lipton RB, Liano Y, Cao G, et al. Determinants of incidence of non-insulin dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1993;138:826-39.
6. National Heart. Lung, and Blood Institute Obesity Education Initiative Expert Panel: clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998;6(Supp 2):51s-210s.
7. Sciamanna CN, Tate DF, Lang W, et al. Who reports receiving advice to lose weight? Results from a multistate survey. Arch Intern Med 2000;160(suppl 2):2334-9.
8. National Institutes of Health and National Heart, Lung, and Blood Institute. North American Association for the Study of Obesity. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults [NIH Publication 00-4084]. Bethesda (MD), National Institutes of Health and National Heart, Lung, and Blood Institute; 2000.
9. Bray GA. Clinical classification and natural history of overweight. In: Bray GA, editors. Contemporary diagnosis and management of obesity. Newtown (PA); Handbooks in Health Careco. 1998; p. 104-30.
10. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993;1119:655.
11. Wing RR, Koeske R, Epstien LH, et al. Long-term effects of modest weight loss in type 2 diabetic patients. Arch Intern Med 1987;147:1749-53.
12. Young T, Palt M, Dempsey J, et al. Occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-73.
13. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-4.
14. Shepard JW Jr. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992;13:437-58.
15. Pijl H, Meinders E. Bodyweight change as an adverse effect on drug treatment: mechanisms and management. Drug Safe 1996;14:329.
16. United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes group 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998;128:165-75.
17. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Results of daily measurements. Contraception 1998;58:345-9.
18. The Writing Group for the PEPI Trial: effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995;273:199-208. [correction: JAMA 274:1676].
19. Haarbo J, Marslew U, Gotfredson A, et al. Post-menopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40:1323-6.
20. Hill JO, Wyatt HR, Melanson EL. Genetic and environmental contributions to obesity. Med Clin N Am 2000;84(2):333-46.
21. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998;280: 1374-7.
22. Flegal KM, Troiano RP, Pamuk ER, et al. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995;333:1165-70.
23. Klem ML, Wing RR, McGuire MT, et al. A descriptive study of individuals successful at long-term weight maintenance of substantial weight loss. Am J Clin Nutr 1997;66: 239-56.
24. Despres JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoprotiens, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
25. Lemieux S, Prud'homme D, Bouchard C, et al. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996;64:685.
26. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation [publication WHO/NUT/NCD/98.1]. Geneva, The World Health Organization; 1997.
27. Manson JE, Stampfer MJ, Hennekens, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.
28. Kushner RF, Weinsier RL. Evaluation of the obese patient practical considerations. Med Clin North Am 2000;84(2):387-99.
29. Anderson DA, Wadden TA. Treating the obese patient suggestions for primary care practice. Arch Fam Med 1999;18:156-66.
30. Brownell KD. Dieting readiness. Weight Control Digest 1990;1:1-9.
31. Foster GD, Wadden TA, Vogt RA, et al. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol 1997;65:79-85.
32. Goldstein D, Potvin J. Long-term weight loss: the effect of pharmacologic agents. Am J Clin Nutr 1994;60:647-57.
33. Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diets, behavioral therapy, and their combination: a five year perspective. Int J Obes 1989;13(Suppl 2):39-46.
34. Williamson DF, Pamuk ER, Thun M, et al. Prospective study of intentional weight loss and mortality in never-smoking over-weight U.S. white women aged 40-64 years. Am J Epid 1995;141:1128-41.
35. Price JH, Desmond SM, Krol RA, et al. Family practice physicians' beliefs, attitudes, and practices regarding obesity. Am J Prev Med 1987;3(6):339-45.